Logo image of NG.CA

NOVAGOLD RESOURCES INC (NG.CA) Stock Fundamental Analysis

TSX:NG - Toronto Stock Exchange - CA66987E2069 - Common Stock - Currency: CAD

6.05  -0.36 (-5.62%)

Fundamental Rating

1

Overall NG gets a fundamental rating of 1 out of 10. We evaluated NG against 805 industry peers in the Metals & Mining industry. NG may be in some trouble as it scores bad on both profitability and health. NG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NG has reported negative net income.
In the past year NG has reported a negative cash flow from operations.
NG had negative earnings in each of the past 5 years.
NG had a negative operating cash flow in each of the past 5 years.
NG.CA Yearly Net Income VS EBIT VS OCF VS FCFNG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -43.54%, NG is not doing good in the industry: 62.24% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -43.54%
ROE N/A
ROIC N/A
ROA(3y)-36.73%
ROA(5y)-29.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NG.CA Yearly ROA, ROE, ROICNG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

NG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NG.CA Yearly Profit, Operating, Gross MarginsNG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, NG has about the same amount of shares outstanding.
Compared to 5 years ago, NG has more shares outstanding
The debt/assets ratio for NG is higher compared to a year ago.
NG.CA Yearly Shares OutstandingNG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NG.CA Yearly Total Debt VS Total AssetsNG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

NG has an Altman-Z score of -21.96. This is a bad value and indicates that NG is not financially healthy and even has some risk of bankruptcy.
NG has a Altman-Z score of -21.96. This is in the lower half of the industry: NG underperforms 76.15% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -21.96
ROIC/WACCN/A
WACCN/A
NG.CA Yearly LT Debt VS Equity VS FCFNG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

NG has a Current Ratio of 47.82. This indicates that NG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 47.82, NG belongs to the top of the industry, outperforming 97.89% of the companies in the same industry.
A Quick Ratio of 47.82 indicates that NG has no problem at all paying its short term obligations.
NG's Quick ratio of 47.82 is amongst the best of the industry. NG outperforms 97.89% of its industry peers.
Industry RankSector Rank
Current Ratio 47.82
Quick Ratio 47.82
NG.CA Yearly Current Assets VS Current LiabilitesNG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

NG shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -14.61% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-26.77%
EPS Next 2Y-16.06%
EPS Next 3Y-14.61%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NG.CA Yearly EPS VS EstimatesNG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NG.CA Price Earnings VS Forward Price EarningsNG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 -30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NG.CA Per share dataNG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

A cheap valuation may be justified as NG's earnings are expected to decrease with -14.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.06%
EPS Next 3Y-14.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOVAGOLD RESOURCES INC

TSX:NG (6/5/2025, 7:00:00 PM)

6.05

-0.36 (-5.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-01 2025-04-01/bmo
Earnings (Next)06-24 2025-06-24/amc
Inst Owners52.09%
Inst Owner ChangeN/A
Ins Owners1.1%
Ins Owner ChangeN/A
Market Cap2.42B
Analysts82
Price Target14.11 (133.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.22%
Min EPS beat(2)-45.63%
Max EPS beat(2)27.18%
EPS beat(4)1
Avg EPS beat(4)-39.56%
Min EPS beat(4)-94.17%
Max EPS beat(4)27.18%
EPS beat(8)1
Avg EPS beat(8)-48.66%
EPS beat(12)1
Avg EPS beat(12)-46.31%
EPS beat(16)4
Avg EPS beat(16)-34%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.3%
PT rev (3m)27.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS-0.19
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-36.73%
ROA(5y)-29.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 47.82
Quick Ratio 47.82
Altman-Z -21.96
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-26.77%
EPS Next 2Y-16.06%
EPS Next 3Y-14.61%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-45.68%
EBIT Next 3Y-4.97%
EBIT Next 5YN/A
FCF growth 1Y-17.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.19%
OCF growth 3YN/A
OCF growth 5YN/A